Modulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseases

被引：82

作者：

Gardoni, Fabrizio ^{[1
]}

Bellone, Camilla ^{[2
]}

机构：

[1] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy

[2] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland

来源：

FRONTIERS IN CELLULAR NEUROSCIENCE | 2015年 / 9卷

关键词：

Dopamine; NMDA receptor; AMPA receptors; Addiction; Parkinson disease; Huntington disease; LONG-TERM POTENTIATION; EVOKED SYNAPTIC PLASTICITY; RECEPTOR-MEDIATED EXCITOTOXICITY; STRIATAL PROJECTION NEURONS; TRANSGENIC MOUSE MODEL; GLUR1 AMPA RECEPTOR; NMDA RECEPTOR; PREFRONTAL CORTEX; D-2; RECEPTOR; D1;

D O I：

10.3389/fncel.2015.00025

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Dopamine (DA) plays a major role in motor and cognitive functions as well as in reward processing by regulating glutamatergic inputs. In particular in the striatum the release of DA rapidly influences synaptic transmission modulating both AMPA and NMDA receptors. Several neurodegenerative and neuropsychiatric disorders, including Parkinson, Huntington and addiction related diseases, manifest a dysregulation of glutamate and DA signaling. Here, we will focus our attention on the mechanisms underlying the modulation of the glutamatergic transmission by DA in stnatal circuits.

引用

页数：11

共 50 条

[21] Ethanol Facilitates Glutamatergic Transmission to Dopamine Neurons in the Ventral Tegmental Area
Xiao, Cheng
Shao, Xuesi Max
Olive, M. Foster
Griffin, William C.
Li, Ke-Yong
Krnjevic, Kresimir
Zhou, Chunyi
Ye, Jiang-Hong
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (02) : 307 - 318
[22] Personality, Addiction, Dopamine: Insights from Parkinson's Disease
Dagher, Alain
Robbins, Trevor W.
NEURON, 2009, 61 (04) : 502 - 510
[23] Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking
He, Jin-Gang
Zhou, Hai-Yun
Wang, Fang
Chen, Jian-Guo
BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2023, 3 (02): : 187 - 196
[24] Stress-induced, glucocorticoid-dependent strengthening of glutamatergic synaptic transmission in midbrain dopamine neurons
Daftary, Shabrine S.
Panksepp, Jaak
Dong, Yan
Saal, Daniel B.
NEUROSCIENCE LETTERS, 2009, 452 (03) : 273 - 276
[25] Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms
Chefer, V. I.
Denoroy, L.
Zapata, A.
Shippenberg, T. S.
EUROPEAN JOURNAL OF NEUROSCIENCE, 2009, 30 (02) : 272 - 278
[26] Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation
Rangel-Barajas, Claudia
Rebec, George V.
JOURNAL OF HUNTINGTONS DISEASE, 2016, 5 (04) : 303 - 331
[27] METHAMPHETAMINE AND DOPAMINE NEUROTOXICITY - DIFFERENTIAL-EFFECTS OF AGENTS INTERFERING WITH GLUTAMATERGIC TRANSMISSION
BOIREAU, A
BORDIER, F
DUBEDAT, P
DOBLE, A
NEUROSCIENCE LETTERS, 1995, 195 (01) : 9 - 12
[28] Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion
Buendia, Jose de Jesus Aceves
Tiroshi, Lior
Chiu, Wei-Hua
Goldberg, Joshua A.
EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (06) : 824 - 833
[29] Neurotrophin-dependent modulation of glutamatergic synaptic transmission in the mammalian CNS
Lessmann, V
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1998, 31 (05): : 667 - 674
[30] Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, Rajnish K.
Beal, M. Flint
MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 55 : 101 - 114

← 1 2 3 4 5 →